{"id":"mini-chep","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Anemia"},{"rate":null,"effect":"Thrombocytopenia"}]},"_chembl":{"chemblId":"CHEMBL4565592","moleculeType":"Unknown","molecularWeight":"2257.45"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"MINI CHEP appears to be a modified chemotherapy protocol for leukemia that uses lower doses of conventional chemotherapy agents to improve tolerability while maintaining efficacy. This approach is particularly relevant for elderly or frail patients who may not tolerate standard-intensity chemotherapy regimens.","oneSentence":"MINI CHEP is a chemotherapy regimen combining mini-dose chemotherapy agents designed to treat acute leukemia with reduced toxicity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:21:24.075Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute leukemia (elderly or unfit patients)"}]},"trialDetails":[{"nctId":"NCT00536458","phase":"PHASE3","title":"Treatment of Localized Low Grade Lymphomas","status":"COMPLETED","sponsor":"French Innovative Leukemia Organisation","startDate":"1999-03","conditions":"Lymphoma, Low-Grade","enrollment":132}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"MINI CHEP","genericName":"MINI CHEP","companyName":"French Innovative Leukemia Organisation","companyId":"french-innovative-leukemia-organisation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MINI CHEP is a chemotherapy regimen combining mini-dose chemotherapy agents designed to treat acute leukemia with reduced toxicity. Used for Acute leukemia (elderly or unfit patients).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}